The DIA Conferences are an international platform for stakeholders to meet and discuss current opportunities and challenges in the healthcare sector. At the DIA Europe 2019 conference, which recently took place in Vienna, Rocco Falchetto spoke about his experience in the development as well as approval and access discussions of the afamelanotide therapy. Through this experience, Rocco has become passionate about the inclusion of patient insights and patient preferences in the medicines lifecycle and about sharing his story to illustrate the challenges and opportunities with giving patients a stronger voice at the decision makers' table. You can read a summary of his and other participants' contributions here: DIA Europe - Patients Get Their Say